Quent Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-160
| Closed | -$24.1K | – | 486 |
|
|
2025
Q1 | $24.1K | Buy |
160
+4
| +3% | +$602 | ﹤0.01% | 726 |
|
|
2024
Q4 | $28.8K | Hold |
156
| – | – | ﹤0.01% | 717 |
|
|
2024
Q3 | $30.7K | Hold |
156
| – | – | ﹤0.01% | 782 |
|
|
2024
Q2 | $32.2K | Sell |
156
-24
| -13% | -$4.96K | ﹤0.01% | 742 |
|
|
2024
Q1 | $48.8K | Buy |
180
+1
| +0.6% | +$271 | 0.01% | 671 |
|
|
2023
Q4 | $42.3K | Sell |
179
-12
| -6% | -$2.84K | 0.01% | 660 |
|
|
2023
Q3 | $37.4K | Sell |
191
-13
| -6% | -$2.55K | 0.01% | 659 |
|
|
2023
Q2 | $42.9K | Hold |
204
| – | – | 0.01% | 626 |
|
|
2023
Q1 | $41.2K | Buy |
204
+6
| +3% | +$1.21K | 0.01% | 638 |
|
|
2022
Q4 | $43.1K | Hold |
198
| – | – | 0.01% | 620 |
|
|
2022
Q3 | $39K | Buy |
198
+44
| +29% | +$8.67K | 0.01% | 608 |
|
|
2022
Q2 | $33K | Hold |
154
| – | – | 0.01% | 616 |
|
|
2022
Q1 | $44K | Buy |
154
+38
| +33% | +$10.9K | 0.01% | 630 |
|
|
2021
Q4 | $44K | Buy |
+116
| New | +$44K | 0.01% | 580 |
|